2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
Seattle Children's Hospital, Seattle, Washington.
Sarah
S
Ringold
Pamela F
PF
Weiss
Timothy
T
Beukelman
Esi Morgan
EM
Dewitt
Norman T
NT
Ilowite
Yukiko
Y
Kimura
Ronald M
RM
Laxer
Daniel J
DJ
Lovell
Peter A
PA
Nigrovic
Angela Byun
AB
Robinson
Richard K
RK
Vehe
D001171:Arthritis, Juvenile / Q000188:drug therapy* / Q000276:immunology; D001688:Biological Products / Q000009:adverse effects*; D002648:Child; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008403:Mass Screening / Q000592:standards*; D011237:Predictive Value of Tests; D012219:Rheumatology / Q000592:standards*; D012307:Risk Factors; D012955:Societies, Medical / Q000592:standards*; D014376:Tuberculosis / Q000175:diagnosis* / Q000276:immunology / Q000382:microbiology; D014481:United States
D001688:Biological Products; D007166:Immunosuppressive Agents